Stacy Lawrence

Key takeaways: The COVID-19 pandemic spurred telehealth use, and now both consumers and healthcare providers find value in virtual visits. Both report increased interaction and better outcomes. Many consumers find value in a hybrid model of care, which combines both in-person visits and telehealth. No-show rates for telehealth visits may be a pitfall for providers. mixetto/E+ via Getty Image In-person versus virtual care. Texting with a healthcare provider or seeing them in the office.

Editas Medicine ($EDIT) has nabbed former VP of rare disease clinical development Dr. Gerald Cox from Sanofi Genzyme ($SNY) to become its CMO. The move comes as the genome editing company plans to move into the clinic next year. The Cambridge, MA-based company nabbed another pharma exec earlier this year, the former VP of genetically defined diseases and genomics at Bristol-Myers Squibb ($BMY), Charles Albright, to serve as its CSO.